Cargando…
Anti-Müllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review
BACKGROUND: Female patients undergoing anticancer treatment are at elevated risk of adverse ovarian outcomes including infertility and premature ovarian insufficiency (POI), which is associated with short- and long-term health risks. Anti-Müllerian hormone (AMH) is a key biomarker of ovarian reserve...
Autores principales: | Anderson, Richard A, Cameron, David, Clatot, Florian, Demeestere, Isabelle, Lambertini, Matteo, Nelson, Scott M, Peccatori, Fedro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071067/ https://www.ncbi.nlm.nih.gov/pubmed/35199161 http://dx.doi.org/10.1093/humupd/dmac004 |
Ejemplares similares
-
Study of Serum Anti-Mullerian Hormone in the Diagnosis of Ovarian Reserve Function in Patients with Premature Ovarian Insufficiency
por: Cai, Yan, et al.
Publicado: (2022) -
Retracted: Study of Serum Anti-Mullerian Hormone in the Diagnosis of Ovarian Reserve Function in Patients with Premature Ovarian Insufficiency
por: International, BioMed Research
Publicado: (2023) -
Diagnostic and predictive accuracy of anti-mullerian hormone for ovarian function after chemotherapy in premenopausal women with early breast cancer
por: Anderson, Richard A., et al.
Publicado: (2022) -
Anti-Mullerian Hormone as a Marker of Ovarian Reserve and Function
por: Sinha, Sudwita, et al.
Publicado: (2022) -
Anti-Mullerian Hormone: Above and Beyond Conventional Ovarian Reserve Markers
por: Jamil, Zehra, et al.
Publicado: (2016)